ClinicalTrials.govclosed
Olanzapine Impact on First-line Immunotherapy for Advanced EGFR-negative NSCLC
ClinicalTrials.gov study NCT06554613. IPD Sharing: NO. Countries: 0. Publications: 2.
ShareScore
32/100
Overall dataset sharing score
Score breakdown
These five areas show where the dataset supports — or may limit — practical reuse.
- Stewardship
- 12
- Harmonization
- 12
- Access
- 0
- Reuse readiness
- 0
- Engagement
- 8